Precision BioSciences, Inc. (DTIL)

7.57 +0.05 (+0.66%) USD  |  NASDAQ  |  May 07, 10:54
More

Precision BioSciences SG&A Expense (TTM) : 23.69M for March 31, 2026

SG&A Expense (TTM) Chart

View SG&A Expense (TTM) for DTIL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks
Start Trial
TG Therapeutics, Inc. 181.70M
Axsome Therapeutics, Inc. 449.81M
Cartesian Therapeutics, Inc. 30.27M
AnaptysBio, Inc. 50.74M
MindWalk Holdings Corp. 13.29M